We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTIC
4526
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14K ﹤0.01%
5,605
-59,349
-91% -$142K
BSX icon
4527
PUT
Boston Scientific
BSX
$69.5B
$13K ﹤0.01%
300
DWX icon
4528
State Street SPDR S&P International Dividend ETF
DWX
$529M
$13K ﹤0.01%
+320
New +$12.7K
FONR
4529
DELISTED
Fonar
FONR
$13K ﹤0.01%
721
-13,709
-95% -$245K
GPRO icon
4530
CALL
GoPro
GPRO
$130M
$13K ﹤0.01%
1,100
IWX icon
4531
iShares Russell Top 200 Value ETF
IWX
$3.98B
$13K ﹤0.01%
+202
New +$13.4K
PEBK icon
4532
Peoples Bancorp of North Carolina
PEBK
$229M
$13K ﹤0.01%
511
-5,014
-91% -$122K
SMDV icon
4533
ProShares Russell 2000 Dividend Growers ETF
SMDV
$695M
$13K ﹤0.01%
+199
New +$13.2K
TUSK icon
4534
Mammoth Energy Services
TUSK
$128M
$13K ﹤0.01%
2,872
+546
+23% +$2.25K
VONV icon
4535
Vanguard Russell 1000 Value ETF
VONV
$20.7B
$13K ﹤0.01%
+190
New +$13.2K
ALPN
4536
DELISTED
Alpine Immune Sciences Inc
ALPN
$13K ﹤0.01%
1,469
-12,636
-90% -$137K
AXLA
4537
DELISTED
Axcella Health Inc. Common Stock
AXLA
$13K ﹤0.01%
127
-391
-75% -$38.8K
ELOX
4538
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$13K ﹤0.01%
161
-396
-71% -$33K
PFSW
4539
DELISTED
PFSweb, Inc.
PFSW
$13K ﹤0.01%
1,770
-11,532
-87% -$85.4K
NTP
4540
DELISTED
Nam Tai Property Inc.
NTP
$13K ﹤0.01%
467
-1,750
-79% -$36.7K
DRV icon
4541
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.5M
$12K ﹤0.01%
223
DXD icon
4542
ProShares UltraShort Dow 30
DXD
$42.2M
$12K ﹤0.01%
+260
New +$12.6K
EWZS icon
4543
iShares MSCI Brazil Small-Cap ETF
EWZS
$234M
$12K ﹤0.01%
+592
New +$10.8K
FBT icon
4544
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$12K ﹤0.01%
72
FDLO icon
4545
Fidelity Low Volatility Factor ETF
FDLO
$1.44B
$12K ﹤0.01%
+252
New +$11.6K
LARK icon
4546
Landmark Bancorp
LARK
$191M
$12K ﹤0.01%
585
-3,637
-86% -$74.1K
MLSS icon
4547
Milestone Scientific
MLSS
$35.3M
$12K ﹤0.01%
5,083
-33,392
-87% -$81K
NGVC icon
4548
Vitamin Cottage Natural Grocers
NGVC
$739M
$12K ﹤0.01%
1,168
-6,456
-85% -$87.4K
OPTN
4549
DELISTED
OptiNose
OPTN
$12K ﹤0.01%
259
-1,691
-87% -$86.3K
PSP icon
4550
Invesco Global Listed Private Equity ETF
PSP
$232M
$12K ﹤0.01%
+155
New +$12.1K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.